|
Index of reports
> Cases with Exomphalos ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Truvada where reactions include exomphalos. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14
Patient:
Reactions: Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Intelence
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Epivir
Indication: Maternal Exposure Timing Unspecified
Ziagen
Indication: Maternal Exposure Timing Unspecified
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-03
Patient:
Reactions: Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Intelence
Indication: Maternal Exposure Timing Unspecified
Ziagen
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Epivir
Indication: Maternal Exposure Timing Unspecified
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-23
Patient:
Reactions: Death, Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Intelence
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Ziagen
Indication: Maternal Exposure Timing Unspecified
Epivir
Indication: Maternal Exposure Timing Unspecified
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-18
Patient:
Reactions: Exomphalos
Drug(s) suspected as cause:
Reyataz
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-21
Ziagen
Indication: Foetal Exposure During Pregnancy
End date: 2011-06-21
Cocaine
Indication: Foetal Exposure During Pregnancy
Truvada
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-21
Epivir
Indication: Foetal Exposure During Pregnancy
End date: 2011-06-21
Intelence
Indication: Foetal Exposure During Pregnancy
End date: 2011-06-21
Norvir
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-21
Bactrim
Indication: Foetal Exposure During Pregnancy
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-06
Patient:
Reactions: Death, Foetal Exposure During Pregnancy, Exomphalos
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Epivir
Indication: Maternal Exposure Timing Unspecified
Intelence
Indication: Maternal Exposure Timing Unspecified
Ziagen
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-06
Patient:
Reactions: Death, Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Epivir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Intelence
Indication: Maternal Exposure Timing Unspecified
Ziagen
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-28
Patient:
Reactions: Maternal Drugs Affecting Foetus, Maternal Exposure During Pregnancy, Exomphalos, Cell Death, Abortion Spontaneous
Drug(s) suspected as cause:
Ziagen
Indication: Foetal Exposure During Pregnancy
End date: 2011-06-21
Reyataz
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-21
Norvir
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-21
Epivir
Indication: Foetal Exposure During Pregnancy
End date: 2011-06-21
Bactrim
Indication: Foetal Exposure During Pregnancy
Intelence
Indication: Foetal Exposure During Pregnancy
End date: 2011-06-21
Truvada
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-21
Cocaine
Indication: Foetal Exposure During Pregnancy
Possible Truvada side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-22
Patient:
Reactions: Death, Premature Rupture of Membranes, Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Ziagen
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Intelence
Indication: Maternal Exposure Timing Unspecified
Epivir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Truvada side effects in male
Reported by a health professional (non-physician/pharmacist) on 2011-10-12
Patient: male, weighing 3.4 kg (7.4 pounds)
Reactions: Gastroschisis, Abdominal Hernia, Maternal Drugs Affecting Foetus, Cardiac Murmur, Cryptorchism, Congenital Anomaly, Abdominal Distension, Exomphalos, Umbilical Hernia
Drug(s) suspected as cause:
Lamivudine
Dosage: 1200 mg (1200 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Retrovir
Dosage: 600 mg (600 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Truvada
Dosage: 300 mg, transplacental
Indication: HIV Infection
Viracept
Dosage: 2500 mg (2500 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Viread
Dosage: 300 mg (300 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-06-06
End date: 2004-09-10
Zidovudine
Dosage: 600 mg (600 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Indinivir Sulfate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2004-06-01
End date: 2004-07-20
Kaletra
Dosage: 600 mg (600 mg, 1 in 1 d), transplacental
Indication: HIV Infection
Start date: 2001-06-01
Other drugs received by patient: Folic Acid
|
